Pertec Medical Announces Allurion Ingestible Weight-Loss Gastric Balloon – Featured in Artery New Product Showcase Episode 138

This is globalUniqueA "black tech" weight-loss innovation—the Allurion swallowable gastric balloon for weight loss—truly delivers a non-invasive, painless, anesthesia-free, and hospitalization-free experience. Unlike traditional bariatric surgery, its placement requires no incisions, no endoscopy, and no anesthesia. Patients with obesity simply swallow it like a capsule; within approximately 15 minutes, once imaging confirms that the balloon has reached the stomach, the placement is complete.

After being inflated in the stomach, the balloon occupies approximately 500 mL of space, helping obese patients naturally reduce their food intake per meal and achieve more sustained satiety by delaying gastric emptying. Studies have shown that users can lose 10%–15% of their body weight during the period the balloon is in place, with even more significant results when combined with professional nutritional guidance.

What provides particular peace of mind is that the Allurion swallowable weight-loss gastric balloon is made from specialized materials. Approximately four months after placement, its valve automatically opens, allowing the balloon to deflate and pass naturally through the digestive system without requiring any further medical intervention. To date, this technology has served over 200,000 users worldwide across Asia, Europe, the Middle East, South America, and other regions, with its safety and efficacy extensively validated. Many users report that during the months with the balloon in place, they gradually established healthy eating habits, enabling them to maintain their weight loss effectively even after the balloon was expelled.

For patients with obesity or their loved ones who are troubled by weight fluctuations and have concerns about surgery or endoscopic procedures, the Allurion swallowable gastric balloon may offer a scientific and gentle starting point. No leave is required for recovery; the procedure can be completed during a lunch break, allowing patients to return to work and daily life in the afternoon. Let weight management no longer be an arduous tug-of-war, but rather a safe, easy, and sustainable health transformation.

April 28 (Tuesday) 16:00, VCBeat's New Product Review Issue 138 invitesZhang Peng, Director of the Department of Bariatric and Metabolic Surgery at Beijing Friendship Hospital, Capital Medical University; Yu Jiahui, Attending Physician at the Gastrointestinal Minimally Invasive Center & Center for Obesity and Metabolic Diseases at Chengdu Third People's Hospital;Qu Zhi, General Manager of Perlove Medical, in-depth sharing of the Allurion Swallowable Weight Loss Gastric Balloon in the live broadcast roomClinical Value, Target Population, Practical Cases, and Industry Outlook, to jointly explore the current status and future of non-invasive weight loss technologies.

Scan the QR code in the poster below to register for the live broadcast.

Zhang Peng

Chief Physician

Professor

Ph.D. Supervisor

Director, Department of Bariatric and Metabolic Surgery, Beijing Friendship Hospital, Capital Medical University

Director, Beijing Center for Quality Control and Improvement in Bariatric and Metabolic Surgery

President, Branch of Bariatric and Metabolic Physicians, Beijing Medical Doctor Association

Postdoctoral Fellow in Surgery, University of California, San Francisco Medical Center

Fellowship in Metabolic and Bariatric Surgery at Duke University, USA

Certified Physician by the American Society for Metabolic and Bariatric Surgery

Shanghai Pujiang Talent Program

Executive Chairman of the Editorial Committee for the "National Health Commission Guidelines for the Diagnosis and Treatment of Obesity (2024 Edition)"

Principal Investigator of the Project “Promotion and Application of Precision Subtyping in the Treatment of Extreme Obesity” under the National Key R&D Program of China during the 14th Five-Year Plan Period

Secretary-General, Committee on Weight Loss and Metabolic Surgery, Expert Committee on Capacity Building and Continuing Education, National Health Commission

Deputy Head, Obesity and Nutritional Metabolism Collaboration Group, Parenteral and Enteral Nutrition Branch of the Chinese Medical Association

Deputy Head, Obesity and Metabolic Surgery Expert Working Group, Branch of Surgeons, Chinese Medical Doctor Association

Vice Chairperson, Committee on Diabetes and Obesity Surgery, Chinese Research Hospital Association

Vice Chairman, Committee on Weight Loss and Metabolic Rehabilitation, Chinese Association of Rehabilitation Medicine

Vice Chairman, Metabolic Surgery Branch, Chinese Medical Promotion Association

Vice Chairman, Metabolic Diseases Professional Committee, Chinese Medical Education Association

Vice Chairperson, Professional Committee on Diabetes Prevention and Rehabilitation, Chinese Association of Rehabilitation Medicine

Fellow of the American College of Surgeons (FACS)

Standing Committee Member of the American Society for Metabolic and Bariatric Surgery (ASMBS)

Research Focus: Clinical and basic research on bariatric surgery for obesity-related diseases, as well as the development and clinical trials of innovative medical devices.

Yu Jiahui

Attending Physician

Chengdu Third People's Hospital, Center for Minimally Invasive Gastrointestinal Surgery & Center for Obesity and Metabolic Diseases

Member of the Endoscopic Weight Loss Therapy Collaborative Group, Chinese Society of Digestive Endocrinology, Chinese Medical Association

Committee Member of the Multidisciplinary Committee on Obesity and Metabolism, Sichuan Medical Association

Standing Committee Member, Weight Loss and Metabolism Professional Committee, Communication Society of Sichuan Medical Association

Standing Committee Member, Branch of Obesity and Metabolic Diseases, Sichuan Provincial Medical Science and Technology Innovation Research Association

Committee Member, Professional Committee on Obesity and Diabetes Surgery, Sichuan International Medical Exchange Promotion Association

Committee Member of the Obesity and Metabolism Professional Committee, Chinese Non-Public Medical Institutions Association

Member of the Gastroesophageal Reflux Disease Professional Committee, Sichuan Medical Communication Association

Deputy Head of the Microecology Group, Gastroenterology Professional Committee, Sichuan Association of Integrative Medicine

Group Leader, Gastroesophageal Reflux Group, Hernia and Abdominal Wall Surgery Branch, Chengdu High-Tech Medical Association

Published over 10 articles in SCI-indexed journals and co-authored one consensus statement.

Qu Zhi

General Manager, Peilte Medical

Served as Director of Strategic Development at Pairte, providing international resource support for the company’s global expansion.

Former Senior Analyst in Private Wealth Management at Goldman Sachs Investment Bank

Bachelor’s degree from Harvard University, Master of Business Administration (MBA) from Tsinghua University, and MBA from Cornell University.

Perlove Medical Technology Co., Ltd. was established in 2002 as a high-tech enterprise integrating research and development, manufacturing, and sales. The company primarily develops and manufactures surgical products such as surgical staplers and minimally invasive endoscopes, delivering its products and services through a global sales network. Perlove holds more than 200 intellectual property rights and has been honored with the National Science and Technology Progress Award. Its products have reached over 2,000 hospitals in more than 60 countries. The company’s sales revenue ranks among the top domestic stapler manufacturers in China and third globally. Perlove is committed to providing professional and systematic surgical solution platforms tailored to patient needs, positioning itself at the forefront of both the domestic industry and the international market. (Note: Internal statistical data of Perlove in 2019; 2019 Analysis Report on China’s Surgical Stapler Industry)

In terms of market presence, Partel Medical has penetrated more than 2,000 hospitals and currently operates in over 60 countries and regions.

• Sales representatives in Europe, Asia, the Middle East, and Latin America are ready to provide customers with support, training, and any other professional assistance as needed.

• The global distribution network is represented by a professional sales team comprising over 90 managers and more than 400 distributors across 60+ countries.

“Artery New Product Showcase” is a live-streaming program dedicated to supporting healthcare companies in launching innovative products. The program’s mission is to empower the milestone launch of every innovative medical product. If your company has plans to release an innovative medical product or achieve a significant milestone and wishes to participate in the “Artery New Product Showcase,” please add our assistant for consultation.